News Post List
A cancer immunotherapy will be offered on the NHS in England to some children and young adults with leukaemia, NHS England announced today.
We’re launching a new Children's Brain Tumour Centre of Excellence to speed up the discovery of new treatments for children with brain tumours.
Half of people invited to bowel screening for the first time in 2015 didn’t take part, according to the latest figures from Cancer Research UK
News digest – blood cancer immunotherapy, energy drink ban, ‘no-deal’ Brexit plans and our Annual Review
In the news this week: engineered cell therapy given initial ‘no’ for NHS in England and we publish our research highlights in our 2017/18 annual review.
Our researchers are working on a new way to improve chemotherapy treatment for aggressive brain tumours, using the precious metal palladium.
A cancer immunotherapy has been provisionally rejected as a treatment for some types of aggressive non-Hodgkin lymphoma on the NHS in England.
The Government have published the first in a series of plans in the event of a 'no-deal' Brexit. But how will this affect cancer patients and research?
As part of our Annual Review 2017/18, our outgoing CEO, Sir Harpal Kumar, shares how our knowledge of cancer has changed in the last 15 years.
The realities of cancer - Mental health issues and changes to energy levels top concerns among cancer patients
Cancer Research UK reveals the changes cancer patients experience and launches product range to support friends and family going through cancer treatment.
In the news this week: the health risks caused by drinking alcohol and scientists discover a promising drug target for some lung cancers.